According to the results of the Pharma & Hospital Report study, Cegedim Customer Information estimates that the volume of medicines dispensed to patients in Romania totaled 699,5 million units, from January to December 2025. This figure reflects a milioane cutii, cu 1.0% decline compared to the previous year, 2024.
The total number of treatment days increased by 2.0%, driven by a 2.0% increase in retail, while the number of hospital treatment days decreased by 1.4%.
In 2025, the value of medicines dispensed to patients in Romania increased by 10.4%, reaching RON 37.5 billion (EUR 7.44 billion) at the wholesale price level. Isolating the impact of the CVR and CV programs, the value of prescription medicines in retail pharmacies increased by 11.4% compared to the previous year, amounting to RON 19.64 billion (EUR 3.89 billion).
Pharma market evolution in Volume
In the fourth quarter of 2025, the total volume of medicines dispensed to patients reached 175.7 million units, marking a 4.2% decrease compared to the same quarter in 2024 (like-for-like market definition). This negative growth was mainly driven by a 4.1% fall in the retail channel, while hospital dispensations declined by 7.1%. Analyzing the segments, prescription medications in pharmacies slightly decreased by 1.2%, whereas over-the-counter (OTC) products, which include both OTC drugs and nutritional supplements, fell by 8.8%.
In 2025, the total volume of medicines and food supplements dispensed to Romanian patients reached 699.5 million units, 1.0% less than the dispensing volume in 2024. Prescription-based medicines (Rx) from pharmacies increased to 417.4 million units (+0.1%), while over-the-counter (OTC) products in pharmacies totaled 251.9 million units, a small decrease of 2.3% from the previous year. In contrast, the hospital segment decreased by 3.6%, accounting for 30.3 million units.
Pharma market evolution in Value
In the final quarter of 2025, the total value of medicines dispensed to patients amounted to RON 9.85 billion, 7.4% up compared to the fourth quarter of 2024. This growth was driven by a 7.7% increase in the retail sector and a 5.8% increase in hospital dispensations. Within the retail channel, the value of prescription (Rx) medicines rose by 11.3%, while over-the-counter (OTC) products decreased by 1.9%.
The Rx medicines in retail, other than those assigned to cost-volume and cost-volume-result contracts, advanced by 11.3% compared to the 4th quarter of 2024.
The total market value in 2025 reached RON 37.5 billion, reflecting a 10.4% increase compared to the previous year. Prescription-based medicines (Rx) from pharmacies generated RON 23.2 billion, marking a 11.7% rise, while over-the-counter (OTC) products totaled RON 8.3 billion, which represents a 5.8% increase. The hospital segment contributed RON 6.0 billion, demonstrating a significant growth of 11.8%.
When isolating the substantial effects of the CVR and CV programs, which amounted to RON 3.6 billion, the value of prescription medicines in retail pharmacies increased by 11.4% from the reference period, reaching RON 19.64 billion (EUR 3.89 billion).
Main players in the local pharmaceutical market
In the last quarter of 2025, the ranking of the top 3 corporations by volume remained unchanged. Sun Pharma (including Terapia) maintained its lead with 17.8 million units, followed by Zentiva (including Labormed and Alvogen) with 16.0 million units, and Servier (including Egis) with 11.8 million units.
In the fourth quarter of 2025, the top three hierarchy by value hasn’t changed vs the previous quarter. AstraZeneca maintained the leading position with RON 560.2 million, followed by Sun Pharma (RON 439.3 million, including Terapia) and Zentiva (including Labormed and Alvogen) with RON 405.3 million.
To consult the complete information on the Romanian pharmaceutical market evolution in the last quarter of 2024 as well as the top players on this market during the same period, access directly our press release.
We also invite you to consult an executive summary of the study for the mentioned period, with graphical representations of the data presented in our article.
Pharma & Hospital Report, a reference study in the analysis of the pharmaceutical market in Romania, has been carried out since 1996.
